z-logo
Premium
Core 2 β1,6‐N‐acetylglucosaminyltransferases and α1,3‐fucosyltransferases regulate the synthesis of O‐glycans on selectin ligands on oral cavity carcinoma cells
Author(s) -
Renkonen Jutta,
Räbinä Jarkko,
Mattila Pirkko,
Grenman Reidar,
Renkonen Risto
Publication year - 2001
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1600-0463.2001.907803.x
Subject(s) - selectin , sialyl lewis x , epitope , extravasation , chemistry , glycoprotein , cell , enzyme , glycan , glycocalyx , microbiology and biotechnology , biochemistry , cancer research , antigen , immunology , cell adhesion molecule , biology
Selectin‐dependent cell binding has importance in the extravasation of blood‐circulating tumor cells and in the generation of metastases. Cell surface glycoproteins decorated with sialylated, fucosylated epitopes, such as sialyl Lewis x (sLe x ), are ligands for selectins. Not only terminal sLe x moieties but also proximal core structures contribute to the formation of binding epitopes for selectins. Core 2 β1,6‐N‐acetylglucosaminyltransferases (C2GnT) and α1,3‐fucosyltransferases (α1,3‐FucT) have been suggested to be the rate‐limiting enzymes in the synthesis of selectin ligands. We analyzed oral cavity epithelial carcinoma cell lines and showed their expression of RNA transcripts for C2GnT and α1,3‐FucT, identified α1,3‐FucT enzyme activities, and analyzed the cell surface sLe x expression levels. Neither the pattern of expressed enzymes nor the α1,3‐FucT activity directly predicted the binding capacity of E‐selectin. However, only the sLe x ‐expressing cell lines were capable of binding to E‐selectin, but not to P‐selectin, thus putatively promoting the selectin‐mediated metastasis. These findings suggest that C2GnT in combination with α1,3‐Fuc‐T contribute to the selectin‐mediated metastasis in oral cavity carcinomas.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here